FDANews

CLARIANT LOSES FAITH IN PHARMA

After failing to reverse falling sales at its Pharmaceutical Fine Chemicals (PFC) division, Clariant has decided to sell the unit to private equity firm Towerbrook for around SFr110m (⁈70m).
In-PharmaTechnologist.com